Response Oncology, Inc. (ROIX)
Response Oncology, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $12. Its beta of -19.14 implies it has historically moved less than the broad market.
Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year. Historically, the company functioned as a comprehensive cancer management firm, providing advanced cancer treatment through its outpatient IMPACT Centers, overseeing the non-medical aspects of oncology practices, compounding and dispensing pharmaceuticals to specific oncologists, and conducting outcomes research for pharmaceutical manufacturers.
Response Oncology, Inc. is most often compared with the following Healthcare names: